Drug development for neurodegenerative diseases is struggling with one of its most intractable barriers: the slow, variable, and subjective nature of clinical endpoints Traditional assessment scales, ...
Recent advances in eye tracking have opened new avenues for evaluating cognitive load during software development. By capturing detailed gaze data, researchers can assess how developers process ...
A new study from UCLA Health shows that a cardiovascular risk score already used routinely in primary care can predict who will develop serious eye diseases years later. Researchers found that people ...